Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Oct 18, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study," is exploring how the gut microbiome, which is the community of bacteria and other microorganisms in our intestines, relates to fatigue and thinking difficulties in cancer patients receiving standard treatments. The goal is to better understand how changes in these microorganisms might affect the well-being of those undergoing cancer care.

To participate in this study, you need to be at least 18 years old and currently diagnosed with cancer. You’ll also need access to a device like a smartphone or tablet to help with participation. If you’re pregnant, breastfeeding, or have other specific health issues, you may not be eligible. If you join the study, you can expect to share information about your experiences with fatigue and mental clarity during your treatment, which could help researchers learn more about how to support cancer patients in the future. The trial is currently looking for participants, so if you think you might be interested, it could be a good opportunity to contribute to important cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Current diagnosis of cancer.
• • 2. Ages 18 and over.
• • 3. Has access to a device (smart phone, computer, tablet) with internet access.
• • 4. Participant is willing and able to give informed consent for participation in the study.
• Exclusion Criteria:
• • 1. Females who are pregnant or lactating.
• • 2. Other medical conditions or medications deemed exclusionary by the study investigators.